Iridium CE hosts expert medical professionals to discuss management, treatment, and other factors of various disease states.
Iridium CE Podcast: From Congress to Clinic
Claim This Podcastby Iridium Continuing Education
6 episodes
Updated Weekly
Accepts GuestsHas SponsorsLocation 🇺🇸
Podcast Overview
Iridium CE hosts expert medical professionals to discuss management, treatment, and other factors of various disease states.
Language
🇺🇲
Publishing Since
1/18/2024
1 verified contact email on file for Iridium CE Podcast: From Congress to Clinic
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
May 2, 2024
LDL-C Lowering in Women and People of Color: Episode One
<p>Join Drs. Kevin Maki and Deepak Bhatt as they discuss the disparities in awareness and treatment of cardiovascular diseases, notably affecting women and people of color, who confront challenges like underrepresentation in clinical trials and socioeconomic factors.</p>
April 26, 2024
LDL-C Lowering in Women and People of Color: Episode Two
<p>Cardiovascular diseases persist as a global health concern. Despite advancements, disparities in awareness and treatment endure, notably affecting women and people of color. Drs. Erin Michos and Keith Ferdinand discuss data, guidelines, and shared decision-making strategies to help combat these issues.</p>
February 22, 2024
Worsening Heart Failure - Episode Four
<a href="https://support.doctorpodcasting.com/media/k2/items/cache/d27af59bb04a0a22e738ec14deca2a87_Generic.jpg"><img align="right" border="0" src="https://support.doctorpodcasting.com/media/k2/items/cache/d27af59bb04a0a22e738ec14deca2a87_S.jpg" alt="worsening-heart-failure-episode-four" /></a><p>Researchers have recognized an increasing need to prevent and treat worsening heart failure due to its association with a rapid escalation of risk. Deepak Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI discusses novel treatments for worsening heart failure.</p>
6 total episodes available
Deep-dive analytics for Iridium CE Podcast: From Congress to Clinic
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Iridium CE Podcast: From Congress to Clinic?
- How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 6 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.